Abstract
Multiple system atrophy (MSA) is characterized by the formation of oligodendroglial cytoplasmic inclusions (GCIs) consisting of α-synuclein filaments. αB-crystallin, a small chaperone protein that binds to unfolded proteins and inhibits aggregation, has been documented in GCIs. We investigated the relative abundance and speciation of αB-crystallin in GCIs in MSA brains. We also examined the influence of αB-crystallin on the formation of cytoplasmic inclusions in cultured glial cells. Immunohistochemistry and confocal microscopy revealed αB-crystallin is a prominent component of GCIs, more abundant than in Lewy bodies in Lewy body dementia. One- and two-dimensional gel electrophoresis and mass spectrometric analysis of GCIs immunopurified from MSA brains indicated that αB-crystallin is a major protein component with multiple post-translationally modified species. In cultured C6 glioma cells treated with the proteasomal inhibitor, lactacystin, to induce accumulation of ubiquitinated proteins, a subset of cells showed increased cytoplasmic staining for αB-crystallin. Proteasomeinhibited cells transfected with GFP-tagged α-synuclein resulted in ubiquitin- and αB-crystallin-positive aggregates resembling GCIs in MSA brains. Our results indicate that αB-crystallin is a major chaperone in MSA, and suggest a role of the protein in the formation of inclusion bodies in glial cells.
Similar content being viewed by others
Abbreviations
- MSA:
-
multiple system atrophy
- PD:
-
Parkinson’s disease
- DLB:
-
Dementia with Lewy bodies
- LB:
-
Lewy body
- GCI:
-
glial cytoplasmic inclusion
- PTM:
-
posttranslational modification
- ESI:
-
electrospray ionisation
- MS:
-
mass spectrometry
- SDS-PAGE:
-
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
- CHAPS:
-
3-[(3-Cholamidopropyl) dimethyl-ammonio]-1-propanesulfonate
References
Aki T, K Yoshidaa and Y Mizukami (2003) The mechanism of αB-crystallin gene expression by proteasome inhibition.Biochem. Biophys. Res. Commun. 311, 162–167.
Aquilina JA, JL Benesch, LL Ding, O Yaron, J Horwitz and CV Robinson (2004) Phosphorylation of αB-crystallin alters chaperone function through loss of dimeric substructure.J. Biol. Chem. 279, 28675–28680.
Berke SJ and HL Paulson (2003) Protein aggregation and the ubiquitin proteasome pathway, gaining the UPPer hand on neurodegeneration.Curr. Opin. Genet. Dev. 13, 253–261.
Chavez Zobel AT, A Loranger, N Marceau, JR Theriault, H Lambert and J Landry (2003) Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathy-causing R120G ?B-crystallin mutant.Hum. Mol. Genet. 12, 1609–1620.
Clark JI and PJ Muchowski (2000) Small heat-shock proteins and their potential role in human disease.Curr. Opin. Struct. Biol. 10, 52–59.
Colvis CM, Y Duglas-Tabor, KB Werth, NE Vieira, JA Kowalak, A Janjani, AL Yergey and DL Garland (2000) Tracking pathology with proteomics, identification ofin vivo degradation products of αB-crystallin.Electrophoresis 21, 2219–2227.
Conconi M, L Djavadi-Ohaniance, W Uerkvitz, KB Hendil and B Friguet (1999) Conformational changes in the 20S proteasome upon macromolecular ligand binding analyzed with monoclonal antibodies.Arch. Biochem. Biophys. 362, 325–328.
Dalle-Donne I, R Rossi, A Milzani, P Di Simplicio and R Colombo (2001) The actin cytoskeleton response to oxidants, from small heat shock protein phosphorylation to changes in the redox state of actin itself.Free Radic. Biol. Med. 31, 1624–1632.
Dabir DV, JQ Trojanowski, C Richter-Landsberg, VM Lee and MS Forman (2004) Expression of the small heat-shock protein αB-crystallin in tauopathies with glial pathology.Am. J. Pathol. 164, 155–166.
Derham BK and JJ Harding (1999) α-Crystallin as a molecular chaperone.Prog. Retin. Eye Res. 18, 463–509.
Derham BK and JJ Harding (2002) Effects of modifications of α-crystallin on its chaperone and other properties.Biochem. J. 364, 711–717.
Gai WP, JH Power, PC Blumbergs and WW Blessing (1998) Multiple-system atrophy, a new α-synuclein disease?Lancet 352, 547–548.
Gai WP, JH Power, PC Blumbergs, JG Culvenor and PH Jensen (1999) α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components.J. Neurochem. 73, 2093–2100.
Garcia-Mata R, YS Gao and E Sztul (2002) Hassles with taking out the garbage: aggravating aggresomes.Traffic. 3, 388–396.
Goedert M. (2001) α-Synuclein and neurodegenerative diseases.Nat. Rev. Neurosci. 2, 492–501.
Goers J, AB Manning-Bog, AL McCormack, IS Millett, S Doniach, DA Di Monte, VN Uversky and AL Fink (2003) Nuclear localization of α-synuclein and its interaction with histones.Biochemistry 42, 8465–8471.
Goldbaum O and C Richter-Landsberg (2004) Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture.J. Neurosci. 24, 5748–5757.
Gordon C (2002) The intracellular localization of the proteasome.Curr. Top. Microbiol. Immunol. 268, 175–184.
Horwitz J (1992) α-Crystallin can function as a molecular chaperone.Proc. Natl. Acad. Sci. USA 89, 10449–10453.
Horwitz J (2003) α-Crystallin.Exp. Eye Res. 76, 145–153.
Jensen PH and WP Gai (2001) Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration.Adv. Exp. Med. Biol. 487, 129–134.
Kahle PJ, M Neumann, L Ozmen, V Muller, H Jacobsen, W Spooren, B Fuss, B Mallon, WB Macklin, H Fujiwara, M Hasegawa, T Iwatsubo, HA Kretzschmar and C Haass (2002) Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes.EMBO Rep. 3, 583–588.
Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation.Trends Cell. Biol. 10, 524–530.
Lindersson E, R Beedholm, P Hojrup, T Moos, W Gai, KB Hendil and PH Jensen (2004) Proteasomal inhibition by α-synuclein filaments and oligomers.J. Biol. Chem. 279, 12924–12934.
Lin P, DL Smith and JB Smith (1997)In vivo modification of the Cterminal lysine of human lens αB-crystallin.Exp. Eye Res. 65, 673–680.
MacRae TH (2000) Structure and function of small heat shock/α-crystallin proteins: established concepts and emerging ideas.Cell. Mol. LifeSci. 57, 899–913.
McLean PJ, H Kawamata and BT Hyman (2001) α-Synucleinenhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.Neuroscience 104, 901–912.
McNaught KS, P Shashidharan, DP Perl, P Jenner and CW Olanow (2002) Aggresome-related biogenesis of Lewy bodies.Eur. J. Neurosci. 16, 2136–2148.
McNaught KS, DP Perl, AL Brownell and CW Olanow (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson’s disease.Ann. Neurol. 56, 149–162.
McNaught KS, R Belizaire, O Isacson, P Jenner and CW Olanow (2003) Altered proteasomal function in sporadic Parkinson’s disease.Exp. Neurol. 179, 38–46.
Olanow CW, DP Perl, GN DeMartino and KS McNaught (2004) Lewy-body formation is an aggresomerelated process: a hypothesis.Lancet Neurol. 3, 496–503.
Rekas A, CG Adda, JA Aquilina, KJ Barnham, M Sunde, D Galatis, NA Williamson, CL Masters, RF Anders, CV Robinson, R Cappai and JA Carver (2004) Interaction of the molecular chaperone αB-crystallin with α-synuclein: effects on amyloid fibril formation and chaperone activity.J. Mol. Biol. 340, 1167–1183.
Richter-Landsberg C, M Gorath, JQ Trojanowski and VM Lee (2000) α-synuclein is developmentally expressed in cultured rat brain oligodendrocytes.J. Neurosci. Res. 62, 9–14.
van Rijk AF and H Bloemendal (2000) α-B-crystallin in neuropathology.Ophthalmologica 214, 7–12.
Sherman MY and AL Goldberg (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.Neuron 29, 15–32.
Verschuure P, Y Croes, PR van den Ijssel, RA Quinlan, WW de Jong and WC Boelens (2002) Translocation of small heat shock proteins to the actin cytoskeleton upon proteasomal inhibition.J. Mol. Cell. Cardiol. 34, 117–128.
Vicart P, A Caron, P Guicheney, Z Li, MC Prevost, A Faure, D Chateau, F Chapon, F Tome, JM Dupret, D Paulin and M Fardeau (1998) A missense mutation in the αB-crystallin chaperone gene causes a desminrelated myopathy.Nat. Genet. 20, 92–95.
Wakabayashi K, M Yoshimoto, S Tsuji and H Takahashi (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.Neurosci. Lett. 249, 180–182.
Wenning GK, C Colosimo, F Geser and W Poewe (2004) Multiple system atrophy.Lancet Neurol. 3, 93–103.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pountney, D.L., Treweek, T.M., Chataway, T. et al. αB-Crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. neurotox res 7, 77–85 (2005). https://doi.org/10.1007/BF03033778
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033778